ObsEva SA Ordinary Shares
OBSV
OBSV was delisted on the 22nd of March, 2023.
34 hedge funds and large institutions have $1.94M invested in ObsEva SA Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 10 closing their positions.
200% more call options, than puts
Call options by funds: $3K | Put options by funds: $1K
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
15% less funds holding
Funds holding: 40 → 34 (-6)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
92% less capital invested
Capital invested by funds: $25.5M → $1.94M (-$23.6M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$107K |
| 2 |
Renaissance Technologies
New York
|
+$88.3K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$76.3K |
| 4 |
Citigroup
New York
|
+$46.3K |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$45.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVM
Medicxi Ventures Management
St. Helier,
Jersey
|
-$944K |
| 2 |
TAM
Tucker Asset Management
Littleton,
Colorado
|
-$480K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$322K |
| 4 |
Millennium Management
New York
|
-$192K |
| 5 |
State Street
Boston,
Massachusetts
|
-$182K |
OBSV Hedge Fund Activity: Q3 2022 in Review
34 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ObsEva SA Ordinary Shares (OBSV) for Q3 2022, worth a combined $1.94M — down 92% from $25.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of OBSV and 4 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 9 added.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $107K. The largest seller was Medicxi Ventures Management, exiting entirely with an estimated $944K sold.
- 34 institutional investors held ObsEva SA Ordinary Shares (OBSV) as of Q3 2022, down from 40 in Q2 2022.
- Funds reported $1.94M of ObsEva SA Ordinary Shares stock for Q3 2022, down 92% quarter-over-quarter.
- 4 funds opened new ObsEva SA Ordinary Shares positions in Q3 2022 and 10 closed out, a net change of -6 holders.
- The largest ObsEva SA Ordinary Shares buyer in Q3 2022 was Two Sigma Investments, an estimated $107K added.
- The largest ObsEva SA Ordinary Shares seller in Q3 2022 was Medicxi Ventures Management, an estimated $944K sold.
Based on aggregated 13F filings for Q3 2022.